Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-06
2009-10-13
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S255050, C514S275000, C544S122000, C544S295000, C544S323000, C544S324000
Reexamination Certificate
active
07601714
ABSTRACT:
Disclosed are novel compounds of formula (I):wherein X, Y, R1, R2and R3are as defined herein, which are useful as inhibitors of PKC-theta and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC-theta, including immunological disorders and type II diabetes. This invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
REFERENCES:
patent: 6432963 (2002-08-01), Hisamichi et al.
patent: 2003/0171359 (2003-09-01), Dahmann et al.
patent: 2004/0242613 (2004-12-01), Cardozo et al.
patent: WO 97/19065 (1997-05-01), None
patent: WO 00/75113 (2000-12-01), None
patent: WO 01/00213 (2001-01-01), None
patent: WO 02/096887 (2002-12-01), None
patent: WO 02/096888 (2002-12-01), None
patent: WO 03/032997 (2003-04-01), None
patent: WO 03/106451 (2003-12-01), None
patent: WO 2004/067516 (2004-08-01), None
Ulrich, Chapter 4: Crystallization, Kirk-Othmer Encyclopedia of Chemical Technology, Aug. 2002.
Vippagunta et al., Cyrstalline Solids, Advanced Drug Delivery Reviews, 48, pp. 3-26, 2001.
West, Solid Solutions, Solid State Chemistry and its applications, pp. 358 & 365, 1988.
Casanova et al., PubMed Abstract (Rev Neurol 28(9):909-15) May 1999.
Hayashi et al., Protein Kinase C theta (PKCθ): A key role in T cell life and death, Pharmacological Research 55 (2007), pp. 537-544.
Barbosa, Jr. Antonio J. M.
Brunette Steven Richard
Hickey Eugene Richard
Kim Jin Mi
Lawlor Michael David
Boehringer Ingelheim Pharmaceuticals Inc.
Datlow Philip I.
Devlin Mary-Ellen M.
Morris Michael P.
Rao Deepak
LandOfFree
Pyrimidine derivatives useful as inhibitors of PKC-theta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine derivatives useful as inhibitors of PKC-theta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives useful as inhibitors of PKC-theta will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4097127